Logo

Affy Facility Closing Tops Most-Read GenomeWeb News Stories Last Week

Sep 18, 2006
 
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 15.
 
1. Affymetrix to Shutter, Consolidate Massachusetts Manufacturing and Development Facility (from Sept. 14)
 
2. Hopkins Study Hints at Role for Next-Gen Methods in Cancer Genome Sequencing; ABI's Agencourt Platform to Be Validated (from Sept. 12)
 
3. MAQC Publishes Results of Large-Scale Comparative Microarray Study, Says Cross-Platform Data Are 'Reproducible and Comparable' (from Sept. 11)
 
4. NIH Picks Lung, Ovarian, and Brain Cancers for Cancer Genome Atlas Project (from Sept. 13)
 
5. Jury Awards Innogenetics $7M in HCV Patent Case Against Abbott (from Sept. 11)
Breaking News
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.